对复合性肺炎链球菌 (Streptococcus pneumoniae Pneumolysin) 免疫生物学特性进行分析
D S Vorobyev1, E S Petukhova2, Yu V Volokh2
1I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia. vorobievdenis@yandex.ru.
Bulletin of experimental biology and medicine
|August 1, 2024
概括
再组合的S. pneumoniae肺清素 (rPly) 与氧化辅助剂显著提高了IgG抗体水平. 这种rPly配方证明了对S. pneumoniae血清型3感染的保护性有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 疫苗开发 疫苗开发
背景情况:
- 肺炎链球菌在全球范围内导致显著的发病率和死亡率.
- 肺清素 (Ply) 是S. pneumoniae的主要毒性因子,也是疫苗开发的目标.
- 诸如氧化 (Al(OH) 3之类的辅助剂经常用于增强疫苗免疫性.
研究的目的:
- 为了比较复合性S. pneumoniae肺炎素 (rPly) 具有或没有Al(OH) 3辅助剂的免疫性.
- 在积极防御模型中评估rPly对S. pneumoniae感染的保护疗效.
主要方法:
- 用单独的rPly或用Al(OH) 3辅助剂对动物进行免疫接种.
- 免疫接种后IgG抗体水平的量化.
- 对S. pneumoniae血清型3的鼻内感染保护的评估.
主要成果:
- 用rPly + Al(OH) 3进行双重免疫,显著增加了IgG水平 (p<0.01).
- 用rPly + Al(OH) 3进行三次免疫接种导致更明显的IgG增加 (p<0.001).
- 用单独的rPly进行三次免疫接种显示IgG的轻微但显著增加 (p<0.05),而没有辅助剂的双次免疫接种并不显著.
- 积极防御测试证实了rPly对S. pneumoniae血清型3鼻内感染的保护性活性.
结论:
- 氧化辅助剂增强了复合性S. pneumoniae pneumolysin的免疫性.
- 重复免疫,特别是使用辅助剂,对于强大的抗体反应至关重要.
- 再组合性肺清素已经证明了对S. pneumoniae感染的保护潜力.
相关概念视频
Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...


